Your browser doesn't support javascript.
loading
Afatinib plus bevacizumab combination after acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: Multicenter, single-arm, phase 2 trial (ABC Study).
Hata, Akito; Katakami, Nobuyuki; Kaji, Reiko; Yokoyama, Toshihide; Kaneda, Toshihiko; Tamiya, Motohiro; Inoue, Takako; Kimura, Hiromi; Yano, Yukihiro; Tamura, Daisuke; Morita, Satoshi; Negoro, Shunichi; The Hanshin Oncology Group, For.
Afiliação
  • Hata A; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Katakami N; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Kaji R; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Yokoyama T; Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, Japan.
  • Kaneda T; Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, Japan.
  • Tamiya M; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Inoue T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Kimura H; Department of Thoracic Oncology, Toneyama National Hospital, National Hospital Organization, Toyonaka, Japan.
  • Yano Y; Department of Thoracic Oncology, Toneyama National Hospital, National Hospital Organization, Toyonaka, Japan.
  • Tamura D; Department of Respiratory Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Morita S; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Negoro S; Department of Medical Oncology, Takarazuka City Hospital, Takarazuka, Japan.
Cancer ; 124(19): 3830-3838, 2018 10 01.
Article em En | MEDLINE | ID: mdl-30192383
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Resistencia a Medicamentos Antineoplásicos / Inibidores de Proteínas Quinases / Bevacizumab / Afatinib / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Resistencia a Medicamentos Antineoplásicos / Inibidores de Proteínas Quinases / Bevacizumab / Afatinib / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão